Your browser doesn't support javascript.
Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection.
Zambrano, Laura D; Ly, Kathleen N; Link-Gelles, Ruth; Newhams, Margaret M; Akande, Manzilat; Wu, Michael J; Feldstein, Leora R; Tarquinio, Keiko M; Sahni, Leila C; Riggs, Becky J; Singh, Aalok R; Fitzgerald, Julie C; Schuster, Jennifer E; Giuliano, John S; Englund, Janet A; Hume, Janet R; Hall, Mark W; Osborne, Christina M; Doymaz, Sule; Rowan, Courtney M; Babbitt, Christopher J; Clouser, Katharine N; Horwitz, Steven M; Chou, Janet; Patel, Manish M; Hobbs, Charlotte; Randolph, Adrienne G; Campbell, Angela P.
  • Zambrano LD; From the COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Ly KN; From the COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Link-Gelles R; From the COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Newhams MM; Public Health Service Commissioned Corps, Rockville, Maryland.
  • Akande M; Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Wu MJ; Department of Pediatrics-Section of Critical Care, The University of Oklahoma College of Medicine, Oklahoma City, Oklahoma.
  • Feldstein LR; From the COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Tarquinio KM; From the COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Sahni LC; Public Health Service Commissioned Corps, Rockville, Maryland.
  • Riggs BJ; Division of Critical Care Medicine, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Singh AR; Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Immunization Project, Houston, Texas.
  • Fitzgerald JC; Department of Anesthesiology and Critical Care Medicine; Division of Pediatric Anesthesiology & Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Schuster JE; Pediatric Critical Care Division, Maria Fareri Children's Hospital at Westchester Medical Center and New York Medical College, Valhalla, New York.
  • Giuliano JS; Division of Critical Care, Department of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Englund JA; Division of Pediatric Infectious Disease, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.
  • Hume JR; Department of Pediatrics, Division of Critical Care, Yale University School of Medicine, New Haven, Connecticut.
  • Hall MW; Department of Pediatrics, School of Medicine, Seattle Children's Research Institute, University of Washington, Seattle, Washington.
  • Osborne CM; Division of Pediatric Critical Care, University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota.
  • Doymaz S; Division of Critical Care Medicine, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio.
  • Rowan CM; Department of Pediatrics, Sections of Critical Care Medicine and Infectious Diseases, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado.
  • Babbitt CJ; Division of Pediatric Critical Care, Department of Pediatrics, SUNY Downstate Health Sciences University, Brooklyn, New York.
  • Clouser KN; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Indiana.
  • Horwitz SM; Division of Pediatric Critical Care Medicine, Miller Children's and Women's Hospital of Long Beach, Long Beach, California.
  • Chou J; Department of Pediatrics, Hackensack Meridian School of Medicine, Hackensack, New Jersey.
  • Patel MM; Department of Pediatrics, Division of Critical Care, Bristol-Myers Squibb Children's Hospital, New Brunswick, New Jersey.
  • Hobbs C; Division of Immunology, Boston Children's Hospital, Boston, Massachusetts.
  • Randolph AG; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; Departments of.
  • Campbell AP; From the COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pediatr Infect Dis J ; 41(11): 891-898, 2022 11 01.
Article in English | MEDLINE | ID: covidwho-2029114
ABSTRACT

BACKGROUND:

Multisystem inflammatory syndrome in children (MIS-C) is a postinfectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related complication that has disproportionately affected racial/ethnic minority children. We conducted a pilot study to investigate risk factors for MIS-C aiming to understand MIS-C disparities.

METHODS:

This case-control study included MIS-C cases and SARS-CoV-2-positive outpatient controls less than 18 years old frequency-matched 41 to cases by age group and site. Patients hospitalized with MIS-C were admitted between March 16 and October 2, 2020, across 17 pediatric hospitals. We evaluated race, ethnicity, social vulnerability index (SVI), insurance status, weight-for-age and underlying medical conditions as risk factors using mixed effects multivariable logistic regression.

RESULTS:

We compared 241 MIS-C cases with 817 outpatient SARS-CoV-2-positive at-risk controls. Cases and controls had similar sex, age and U.S. census region distribution. MIS-C patients were more frequently previously healthy, non-Hispanic Black, residing in higher SVI areas, and in the 95th percentile or higher for weight-for-age. In the multivariable analysis, the likelihood of MIS-C was higher among non-Hispanic Black children [adjusted odds ratio (aOR) 2.07; 95% CI 1.23-3.48]. Additionally, SVI in the 2nd and 3rd tertiles (aOR 1.88; 95% CI 1.18-2.97 and aOR 2.03; 95% CI 1.19-3.47, respectively) were independent factors along with being previously healthy (aOR 1.64; 95% CI 1.18-2.28).

CONCLUSIONS:

In this study, non-Hispanic Black children were more likely to develop MIS-C after adjustment for sociodemographic factors, underlying medical conditions, and weight-for-age. Investigation of the potential contribution of immunologic, environmental, and other factors is warranted.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adolescent / Child / Humans Language: English Journal: Pediatr Infect Dis J Journal subject: Communicable Diseases / Pediatrics Year: 2022 Document Type: Article Affiliation country: INF.0000000000003689

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adolescent / Child / Humans Language: English Journal: Pediatr Infect Dis J Journal subject: Communicable Diseases / Pediatrics Year: 2022 Document Type: Article Affiliation country: INF.0000000000003689